122 related articles for article (PubMed ID: 17297477)
1. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP).
Kim MM; Wiederschain D; Kennedy D; Hansen E; Yuan ZM
Oncogene; 2007 Jun; 26(29):4209-15. PubMed ID: 17297477
[TBL] [Abstract][Full Text] [Related]
2. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
4. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
[TBL] [Abstract][Full Text] [Related]
5. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.
Lu Y; Nikolovska-Coleska Z; Fang X; Gao W; Shangary S; Qiu S; Qin D; Wang S
J Med Chem; 2006 Jun; 49(13):3759-62. PubMed ID: 16789731
[TBL] [Abstract][Full Text] [Related]
7. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
Hu B; Gilkes DM; Chen J
Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
[TBL] [Abstract][Full Text] [Related]
8. RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2.
Chen Y; Zhou S; Wan K; Yu L; Zhao C; Deng H; Ou Q; Qin J; Hu J; Hou Z
Oncogene; 2022 Jun; 41(25):3433-3444. PubMed ID: 35589951
[TBL] [Abstract][Full Text] [Related]
9. The p53 Isoform Deltap53 lacks intrinsic transcriptional activity and reveals the critical role of nuclear import in dominant-negative activity.
Chan WM; Poon RY
Cancer Res; 2007 Mar; 67(5):1959-69. PubMed ID: 17332323
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of p53 by Ras superfamily protein RBEL1A.
Lui K; An J; Montalbano J; Shi J; Corcoran C; He Q; Sun H; Sheikh MS; Huang Y
J Cell Sci; 2013 Jun; 126(Pt 11):2436-45. PubMed ID: 23572512
[TBL] [Abstract][Full Text] [Related]
11. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.
Francoz S; Froment P; Bogaerts S; De Clercq S; Maetens M; Doumont G; Bellefroid E; Marine JC
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3232-7. PubMed ID: 16492744
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human p53 activity and cell localization by alternative splicing.
Ghosh A; Stewart D; Matlashewski G
Mol Cell Biol; 2004 Sep; 24(18):7987-97. PubMed ID: 15340061
[TBL] [Abstract][Full Text] [Related]
13. TXNIP interacts with hEcd to increase p53 stability and activity.
Suh HW; Yun S; Song H; Jung H; Park YJ; Kim TD; Yoon SR; Choi I
Biochem Biophys Res Commun; 2013 Aug; 438(2):264-9. PubMed ID: 23880345
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
15. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
[TBL] [Abstract][Full Text] [Related]
16. Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.
Okoro DR; Arva N; Gao C; Polotskaia A; Puente C; Rosso M; Bargonetti J
PLoS One; 2013; 8(10):e77643. PubMed ID: 24147044
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.
Chen D; Zhang Z; Li M; Wang W; Li Y; Rayburn ER; Hill DL; Wang H; Zhang R
Oncogene; 2007 Aug; 26(35):5029-37. PubMed ID: 17310983
[TBL] [Abstract][Full Text] [Related]
18. Roles for CSN5 in control of p53/MDM2 activities.
Zhang XC; Chen J; Su CH; Yang HY; Lee MH
J Cell Biochem; 2008 Mar; 103(4):1219-30. PubMed ID: 17879958
[TBL] [Abstract][Full Text] [Related]
19. Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
Bergamaschi D; Samuels Y; Zhong S; Lu X
Oncogene; 2005 May; 24(23):3836-41. PubMed ID: 15782125
[TBL] [Abstract][Full Text] [Related]
20. The human orthologue of Drosophila ecdysoneless protein interacts with p53 and regulates its function.
Zhang Y; Chen J; Gurumurthy CB; Kim J; Bhat I; Gao Q; Dimri G; Lee SW; Band H; Band V
Cancer Res; 2006 Jul; 66(14):7167-75. PubMed ID: 16849563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
